New results from the National Institutes of Health’s Researching COVID to Enhance Recovery (RECOVER)-Adult Initiative suggest that 4.5% of COVID-19 survivors have myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), compared with less than 1% of their uninfected counterparts.
ME/CFS, which can be triggered by viral and non-viral infection, causes severe fatigue for at least 6 months and may entail impaired memory, brain fog, dizziness, and muscle or joint pain. Physical or mental activity exacerbates symptoms, which aren’t fully relieved by rest.
RECOVER-Adult is a longitudinal observational study conducted at 83 sites in 33 states, Puerto Rico, and Washington, DC, to research post-COVID conditions such as ME/CFS and long COVID.
Comments closed